Clinical Trial Update: Performance Study Using the OptiScanner on Healthy Diabetics [Phase 1]

View source ↗

Summary

A Phase 1 performance study evaluated the OptiScanner in healthy individuals with diabetes to assess safety and functionality.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Diabetes | Phase 1 | Status: COMPLETED